\-\ Texto\\:\\ \ \(0\)\
\-\ axial\\ contrast\\ enhanced\\ ct\\ images\\ reveal\\ a\\ large\\,\\ heterogeneously\\ enhancing\\ anterior\\ mediastinal\\ mass\\,\\ measuring\\ 6\\.9cm\\ ap\\ by\\ 7\\.4cm\\ transverse\\.\\ \\ no\\ calcification\\ or\\ macroscopic\\ fat\\ is\\ present\\,\\ though\\ central\\ hypodensity\\ consistent\\ with\\ necrosis\\ or\\ cystic\\ degeneration\\ is\\ seen\\ medially\\.\\ \\ an\\ enlarged\\ lymph\\ node\\ is\\ contiguous\\ with\\ the\\ aortic\\ arch\\ superiorly\\,\\ with\\ loss\\ of\\ the\\ fat\\ plane\\ separating\\ the\\ mass\\ from\\ the\\ anterior\\ chest\\ wall\\ seen\\ more\\ inferiorly\\.\ \(0\)\
\-\ hodgkin\\ disease\ \(0\)\
\-\ lymphoma\\,\\ thymic\\ carcinoma\\,\\ invasive\\ thymoma\\,\\ metastatic\\ disease\ \(0\)\
\-\ 41\\ yo\\ woman\\ presents\\ with\\ hemoptysis\\ and\\ pruritus\\,\\ with\\ a\\ \\‚\\Ä\\úchest\\ mass\\‚\\Ä\\ù\\ seen\\ on\\ an\\ outside\\ chest\\ radiograph\\.\ \(1\)\
\-\ per\\ the\\ cleveland\\ clinic\\ online\\ \\(http\\:\\/\\/www\\.clevelandclinicmeded\\.com\\/diseasemanagement\ \(0\)\
\-\ \\/dermatology\\/pruritus\\/pruritus\\.htm\\)\\:\ \(1\)\
\-\ the\\ strongest\\ association\\ of\\ pruritus\\ and\\ malignancy\\ is\\ with\\ hodgkin\\'s\\ disease\\.\\ itching\\ may\\ precede\\ hodgkin\\'s\\ disease\\,\\ and\\ the\\ intensity\\ correlates\\ with\\ the\\ severity\\ of\\ the\\ disease\\.\\ itching\\ is\\ present\\ more\\ on\\ the\\ legs\\ and\\ the\\ lower\\ half\\ of\\ the\\ body\\,\\ is\\ described\\ as\\ burning\\ in\\ quality\\,\\ and\\ is\\ usually\\ more\\ intense\\ at\\ night\\.\\ generalized\\ pruritus\\ has\\ also\\ been\\ described\\ in\\ patients\\ with\\ leukemia\\,\\ but\\ is\\ less\\ intense\\ than\\ in\\ hodgkin\\'s\\ disease\\.\\ the\\ association\\ between\\ solid\\ visceral\\ tumors\\ and\\ pruritus\\ is\\ less\\ clear\\,\\ though\\ pruritus\\ has\\ been\\ reported\\ in\\ patients\\ with\\ cancers\\ of\\ the\\ lung\\,\\ colon\\,\\ breast\\,\\ uterus\\ and\\ prostate\\.\\ the\\ pruritus\\ frequently\\ remits\\ when\\ the\\ malignancy\\ is\\ treated\\ and\\ reappears\\ with\\ relapse\\ of\\ the\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pruritus\\:\\ 0\\.6334320424709138\ \(0\)\
\-\ hodgkin\\:\\ 0\\.2385405955746834\ \(0\)\
\-\ the\\:\\ 0\\.198042703668298\ \(0\)\
\-\ disease\\:\\ 0\\.17155045469334027\ \(0\)\
\-\ itching\\:\\ 0\\.1610913547121375\ \(0\)\
\-\ is\\:\\ 0\\.15988645456972297\ \(0\)\
\-\ with\\:\\ 0\\.11432167237050427\ \(0\)\
\-\ intense\\:\\ 0\\.11022612532405963\ \(0\)\
\-\ association\\:\\ 0\\.10508180087061085\ \(0\)\
\-\ though\\:\\ 0\\.10144472507184883\ \(0\)\
\-\ and\\:\\ 0\\.0965134452082836\ \(0\)\
\-\ more\\:\\ 0\\.09617592097777931\ \(0\)\
\-\ described\\:\\ 0\\.09473940428682537\ \(0\)\
\-\ remits\\:\\ 0\\.09336750222559508\ \(0\)\
\-\ reappears\\:\\ 0\\.09336750222559508\ \(0\)\
\-\ chest\\:\\ 0\\.09245288924664709\ \(0\)\
\-\ strongest\\:\\ 0\\.08921763290665244\ \(0\)\
\-\ malignancy\\:\\ 0\\.08741552603407417\ \(0\)\
\-\ seen\\:\\ 0\\.08245906242535897\ \(0\)\
\-\ cleveland\\:\\ 0\\.08212338444828701\ \(0\)\
\-\ precede\\:\\ 0\\.08212338444828701\ \(0\)\
\-\ less\\:\\ 0\\.0794381511315582\ \(0\)\
\-\ relapse\\:\\ 0\\.07689516741800503\ \(0\)\
\-\ online\\:\\ 0\\.07591968325662225\ \(0\)\
\-\ separating\\:\\ 0\\.07420991191826387\ \(0\)\
\-\ fat\\:\\ 0\\.07263594837278506\ \(0\)\
\-\ burning\\:\\ 0\\.07087926667097892\ \(0\)\
\-\ of\\:\\ 0\\.06855204359259102\ \(0\)\
\-\ been\\:\\ 0\\.06802946750998652\ \(0\)\
\-\ quality\\:\\ 0\\.06793488753155615\ \(0\)\
\-\ visceral\\:\\ 0\\.06793488753155615\ \(0\)\
\-\ mass\\:\\ 0\\.06690251121406714\ \(0\)\
\-\ correlates\\:\\ 0\\.06672939735203628\ \(0\)\
\-\ macroscopic\\:\\ 0\\.0663571804393379\ \(0\)\
\-\ patients\\:\\ 0\\.06568752490319966\ \(0\)\
\-\ thymic\\:\\ 0\\.06531545114655873\ \(0\)\
\-\ anterior\\:\\ 0\\.06519557314204971\ \(0\)\
\-\ thymoma\\:\\ 0\\.06378501821261351\ \(0\)\
\-\ hypodensity\\:\\ 0\\.06350459417592073\ \(0\)\
\-\ cancers\\:\\ 0\\.06270667050127418\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.060629604028177\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.060422832610414985\ \(0\)\
\-\ contiguous\\:\\ 0\\.06022015594648624\ \(0\)\
\-\ present\\:\\ 0\\.05991666783472517\ \(0\)\
\-\ medially\\:\\ 0\\.05963514889367085\ \(0\)\
\-\ plane\\:\\ 0\\.05890377804014275\ \(0\)\
\-\ superiorly\\:\\ 0\\.05872881929991117\ \(0\)\
\-\ in\\:\\ 0\\.058095415989719054\ \(0\)\
\-\ severity\\:\\ 0\\.057581317020948736\ \(0\)\
\-\ legs\\:\\ 0\\.05742740679624826\ \(0\)\
\-\ prostate\\:\\ 0\\.056549597349573474\ \(0\)\
\-\ inferiorly\\:\\ 0\\.05600360992873049\ \(0\)\
\-\ generalized\\:\\ 0\\.05574116382933143\ \(0\)\
\-\ half\\:\\ 0\\.05499193891620427\ \(0\)\
\-\ degeneration\\:\\ 0\\.05429383859037211\ \(0\)\
\-\ 41\\:\\ 0\\.053535355569811566\ \(0\)\
\-\ has\\:\\ 0\\.05333552085987942\ \(0\)\
\-\ leukemia\\:\\ 0\\.05332858415204956\ \(0\)\
\-\ invasive\\:\\ 0\\.05312590748812081\ \(0\)\
\-\ night\\:\\ 0\\.05244656947197874\ \(0\)\
\-\ uterus\\:\\ 0\\.05120982785727798\ \(0\)\
\-\ node\\:\\ 0\\.05018152834869803\ \(0\)\
\-\ arch\\:\\ 0\\.04952569169091813\ \(0\)\
\-\ clinic\\:\\ 0\\.04917871483310691\ \(0\)\
\-\ reveal\\:\\ 0\\.04911070902097856\ \(0\)\
\-\ per\\:\\ 0\\.04845440492299078\ \(0\)\
\-\ frequently\\:\\ 0\\.04807991789005027\ \(0\)\
\-\ mediastinal\\:\\ 0\\.04714350869267664\ \(0\)\
\-\ outside\\:\\ 0\\.04686762036936178\ \(0\)\
\-\ lymph\\:\\ 0\\.04539937781866697\ \(0\)\
\-\ measuring\\:\\ 0\\.04516622794024724\ \(0\)\
\-\ aortic\\:\\ 0\\.04512022859508785\ \(0\)\
\-\ transverse\\:\\ 0\\.044983458135704806\ \(0\)\
\-\ solid\\:\\ 0\\.04475949215142241\ \(0\)\
\-\ an\\:\\ 0\\.04465110588404702\ \(0\)\
\-\ necrosis\\:\\ 0\\.044627427905282284\ \(0\)\
\-\ enhanced\\:\\ 0\\.04445395193753713\ \(0\)\
\-\ colon\\:\\ 0\\.04445395193753713\ \(0\)\
\-\ http\\:\\ 0\\.0431628140860808\ \(0\)\
\-\ tumors\\:\\ 0\\.042937863556843606\ \(0\)\
\-\ breast\\:\\ 0\\.04239621140062021\ \(0\)\
\-\ clear\\:\\ 0\\.042326109502795944\ \(0\)\
\-\ reported\\:\\ 0\\.04205040698534073\ \(0\)\
\-\ ap\\:\\ 0\\.04191529166239467\ \(0\)\
\-\ calcification\\:\\ 0\\.0416830487658595\ \(0\)\
\-\ intensity\\:\\ 0\\.04145595907116992\ \(0\)\
\-\ or\\:\\ 0\\.04062097546080744\ \(0\)\
\-\ enlarged\\:\\ 0\\.03980062848388229\ \(0\)\
\-\ central\\:\\ 0\\.03898770471225099\ \(0\)\
\-\ body\\:\\ 0\\.03842372671361752\ \(0\)\
\-\ radiograph\\:\\ 0\\.03802598013672243\ \(0\)\
\-\ between\\:\\ 0\\.03793459705579883\ \(0\)\
\-\ usually\\:\\ 0\\.03675440932938755\ \(0\)\
\-\ enhancing\\:\\ 0\\.03657361260922398\ \(0\)\
\-\ yo\\:\\ 0\\.0364745330642205\ \(0\)\
\-\ treated\\:\\ 0\\.03635688996358058\ \(0\)\
\-\ loss\\:\\ 0\\.035569206246836446\ \(0\)\
\-\ wall\\:\\ 0\\.03551519642720171\ \(0\)\
\-\ lung\\:\\ 0\\.03551519642720171\ \(0\)\
\-\ when\\:\\ 0\\.035266851974477195\ \(0\)\
\-\ on\\:\\ 0\\.03526547797521086\ \(0\)\
\-\ cystic\\:\\ 0\\.035162236033955685\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0349222121042477\ \(0\)\
\-\ lymphoma\\:\\ 0\\.03477083131066252\ \(0\)\
\-\ axial\\:\\ 0\\.03372425585003653\ \(0\)\
\-\ than\\:\\ 0\\.03309579579860459\ \(0\)\
\-\ metastatic\\:\\ 0\\.032020283614938125\ \(0\)\
\-\ consistent\\:\\ 0\\.0316567300535834\ \(0\)\
\-\ woman\\:\\ 0\\.030406179481980357\ \(0\)\
\-\ lower\\:\\ 0\\.02983389667545142\ \(0\)\
\-\ may\\:\\ 0\\.02938028460585507\ \(0\)\
\-\ large\\:\\ 0\\.02925289868004372\ \(0\)\
\-\ but\\:\\ 0\\.028870600751839923\ \(0\)\
\-\ contrast\\:\\ 0\\.028367221666620635\ \(0\)\
\-\ presents\\:\\ 0\\.02808534947469805\ \(0\)\
\-\ also\\:\\ 0\\.027461800342557574\ \(0\)\
\-\ images\\:\\ 0\\.02700613296856429\ \(0\)\
\-\ by\\:\\ 0\\.024792907495493722\ \(0\)\
\-\ as\\:\\ 0\\.023454617390256945\ \(0\)\
\-\ from\\:\\ 0\\.023187345599272092\ \(0\)\
\-\ ct\\:\\ 0\\.022227045568795737\ \(0\)\
\-\ at\\:\\ 0\\.022052086828564153\ \(0\)\
\-\ no\\:\\ 0\\.0189855635717413\ \(0\)\
